Imeglimin modulates mitochondria biology and facilitates mitokine secretion in 3T3-L1 adipocytes
- 18 May 2024
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 349, 122735
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (22K07403)
This publication has 59 references indexed in Scilit:
- The mitochondrial unfolded protein response and its diverse roles in cellular stressThe International Journal of Biochemistry & Cell Biology, 2021
- The mechanism by which imeglimin inhibits gluconeogenesis in rat liver cellsEndocrinology, Diabetes & Metabolism, 2021
- Imeglimin preserves islet β‐cell mass in Type 2 diabetic ZDF ratsEndocrinology, Diabetes & Metabolism, 2020
- An adipocyte-specific defect in oxidative phosphorylation increases systemic energy expenditure and protects against diet-induced obesity in mouse modelsDiabetologia, 2020
- A review of phenformin, metformin, and imegliminDrug Development Research, 2020
- Berberine-induced activation of AMPK increases hepatic FGF21 expression via NUR77Biochemical and Biophysical Research Communications, 2018
- Integrated stress response stimulates FGF21 expression: Systemic enhancer of longevityCellular Signalling, 2017
- Growth differentiation factor 15 as a useful biomarker for mitochondrial disordersAnnals of Neurology, 2015
- MitohormesisCell Metabolism, 2014
- AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover studyDiabetologia, 2011